This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Connecticut. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Zhi-kang Xu: Innovator in Artificial Bone Composite Structures
Introduction
Zhi-kang Xu is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of artificial bone composite structures. His innovative work focuses on creating materials that can enhance bone regeneration and healing.
Latest Patents
Zhi-kang Xu holds a patent for "Electrospun apatite/polymer nano-composite scaffolds." This invention provides an artificial bone composite structure that includes a fibrous matrix composed of multiple fibers. The structure also incorporates hydroxyapatite (HA) particles, which are dispersed within the fibrous matrix. These HA particles are characterized by controlled size and aspect ratios, and they are aligned along the long axes of the fibers. In some instances, the fibers consist of poly-(L-lactic acid) (PLLA). This innovative approach aims to improve the effectiveness of bone scaffolds in medical applications.
Career Highlights
Zhi-kang Xu is affiliated with the University of Connecticut, where he continues to advance his research in the field of biomaterials. His work has garnered attention for its potential applications in regenerative medicine and tissue engineering.
Collaborations
Zhi-kang Xu collaborates with notable colleagues, including Mei Wei and Fei Peng. Their combined expertise contributes to the advancement of research in artificial bone materials and their applications.
Conclusion
Zhi-kang Xu's contributions to the field of artificial bone composite structures highlight his innovative spirit and dedication to improving medical technologies. His work has the potential to significantly impact the future of bone regeneration therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
